Argentinian Prospective Registry of Patients With Lupus

Launched by SOCIEDAD ARGENTINA DE REUMATOLOGIA · Jul 20, 2022

Keywords

ClinConnect Summary

This clinical trial, called the Argentinian Prospective Registry of Patients With Lupus, aims to gather important information about patients with systemic lupus erythematosus (SLE) in Argentina. SLE is a condition where the immune system mistakenly attacks the body’s own tissues, leading to various health issues. The goal of this study is to create a group of Argentinian patients to better understand their experiences and challenges, especially regarding access to specialized care and treatments.

To participate in the trial, individuals must be at least 18 years old and have been diagnosed with SLE within the last five years. Participants will be asked to provide their consent to take part in the study. This trial is currently recruiting patients, and all genders are welcome to join. By taking part, individuals can contribute to a better understanding of SLE in their region, which may help improve care for future patients. Participants can expect to share their experiences regarding their condition and the healthcare they receive, helping researchers gather valuable "real world" data.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients ≥ 18 years of age
• • Classified as SLE (according to the 1982/1997 American College of Rheumatology criteria and/or Systemic Lupus International Collaborating Clinics criteria for SLE)
• • Less than 5 years from meeting SLE criteria
• • Informed consent signature
• Exclusion Criteria:
• • Diagnosis of other systemic autoimmune diseases or overlap syndromes
• • Patients who have been transferred to other centers